We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Agfa Radiology

Bracco

Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical de... read more Featured Products: More products

Download Mobile App





Bracco Diagnostics Unveils Contrast Media and Device Offerings at RSNA 2019

By MedImaging International staff writers
Posted on 05 Dec 2019
Print article
Image: Multihance Contrast Media (Photo courtesy of Bracco Diagnostics Inc.)
Image: Multihance Contrast Media (Photo courtesy of Bracco Diagnostics Inc.)
Bracco Diagnostics Inc. (Monroe Township, N.J., USA), the US subsidiary of Bracco Imaging S.p.A., highlighted its full scope of offerings and advancements with its diagnostic imaging services and solutions portfolio at the 2019 RSNA Annual Meeting held December 1–6 in Chicago, USA.

Bracco Imaging develops, manufactures, and markets diagnostic imaging agents and solutions that meet medical needs. Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities, including X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers. The diagnostic imaging portfolio is completed by a range of medical devices and advanced administration systems for contrast imaging products.

At RSNA 2019, Bracco Diagnostics highlighted its focus on patient care and the power of choice, giving customers the ability to assess each patient's personal needs and decide upon the best contrast media option for their patients, whether the contrast is for an MRI, X-ray/CT, Ultrasound, or Nuclear Medicine examination. The company also stated its commitment towards smart solutions and innovative technologies to improve workflow, optimize image quality, and maximize efficiency. Bracco Diagnostics expressed its dedication and passion for funding education for the medical community with comprehensive, convenient programs tailored to address today's health care challenges. It offered interactive carousels for RSNA attendees to explore the company’s offerings and clinical breakthroughs to improve outcomes.

"We come to this year's RSNA eager to discuss the science of imaging with our customers and our industry partners," said Cosimo De Pinto, Vice President of Marketing at Bracco. "To say the next few years are going to be transformational would be an understatement. The balance of providing value-based care while riding the wave of technology and innovation can be daunting for our customers, but we believe we are in a unique position at Bracco to support both endeavors. It's an exciting time to be in the field of diagnostic imaging."

Related Links:
Bracco Diagnostics Inc.


Print article

Channels

General/Advanced Imaging

view channel
Image: 3D cardiac map created with the EnSite X EP mapping system with OT (Photo courtesy of Abbott)

New Mapping System Improves Heart Rhythm Management

Thanks to omnipolar technology (OT), a new cardiac mapping system provides 360-degree views of the heart, regardless of catheter orientation. The Abbott (Abbott Park, IL, USA) EnSite X EP with OT system... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Illustration

Global Breast Imaging Systems Market to Reach USD 1.3 Billion by 2024 Due to COVID-19-Led Patient Backlog

The global breast imaging market is expected to be driven by rising incidences of breast cancer, coupled with the huge backlog of women requiring breast cancer screening appointments due to COVID-19.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.